semaglutide com FDA Approves Oral Semaglutide: First GLP-1 Weight Loss Pill Semaglutide: The benefits and risks

The Master Antioxidant Why do we call it the "master" antioxidant

An investigator-blind, multicentre, parallel efficacy, three-arm (two Ayurvedic and Hydroxychloroquine sulfate (HCQS)) drug trial study was conducted on 121 patients for 24 weeks with active moderately severe RA (ACR 1988 classified) using polyherb ( Z

Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure

The Appetite Suppression Problem When appetite is significantly suppressed, total food intake drops, often dramatically

Al-JishiEMeyerBFRashedMSAl-EssaMAl-HamedMHSakatiNet alClinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency